Lithuanian University of Health Sciences   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kaunas Lithuania (2010)

Organization Overview

First Clinical Trial
2012
NCT02248493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Head of the Department of Anaesthesiology, Medical academy, Lithuanian University of Health Sciences | Lithuanian University of Health Sciences | Lithuanian University of Health Sciences, Department of Pulmonology | Lithuanian University of Health Sciences, Department of Rehabilitation | Lithuanian University of Health Sciences Hospital, Endocrinology Unit | Lithuanian university of sciences

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Colorectal Neoplasms (Phase 4)

Myofascial Pain Syndromes (Phase 4)

Obesity (Phase 3)

Pain, Postoperative (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 28